1Ghosh A, Roy A, Matras J, et al. Simvastatin inhibits the activation o{ p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease[J]. J Neurosci, 2009,29: 13543- 13556.
2Santiago M, Hernandez-Romero MC, Machado A, et a. Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not[J]. Eur J Pharmacol, 2009,609 : 58-64.
3Kumar A, Sharma N, Gupta A, et al. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson like symptoms]-J. Brain Res, 2012,1471 :13-22.
4Yan J, Xu Y, Zhu C, et al. Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti- inflammatory responses [J] . PLoS One, 2011, 6 e20945.
5Yan J, Sun J, Huang L, et al. Simvastatin prevents neuroinflammation by inhibiting N-methyl-D-aspartic acid receptor 1 in 6-hydroxydopamine-treated PC12 cells[J]. J Neurosci Res, 2014,92:634-640.
6Wolozin B, Wang SW, Li NC, et al. Simvastatin is associated with a reduced incidence of dementia and Parkinsoffs disease[J]. BMC Med, 2007,5:20-21.
7Lee YC, Lin CH, Wu RM, et al. Discontinuation of statin therapy associates with Parkinson disease: a population-based study [J] . Neurology, 2013, 81 410-416.
8ZhiWH, Zeng YY, Lu ZH, et al. Simvastatin exerts antiamnesic effect in Abeta25-35 -injected mice [J]. CNS Neurosci Ther, 2014,20:218-226.
10Tramontina AC, Wartchow KM, Rodrigues L, et al. The neuroprotective ef{ect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats [J]. J Neural Transm, 2011,118 : 1641-1649.
